Results 11 to 20 of about 843,559 (297)

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection [PDF]

open access: yesClinical and Developmental Immunology, 2013
Monoclonal antibodies are widely used both in infants and in adults for several indications. Humanized monoclonal antibodies (palivizumab) have been used for many years for the prevention of respiratory syncytial virus infection in pediatric populations (
Marcello Lanari   +4 more
doaj   +2 more sources

Tocilizumab but not Siltuximab prevents systemic inflammation in a humanized mouse model [PDF]

open access: yesFrontiers in Immunology
ObjectivesThe present study aimed to assess the therapeutic efficacy of neutralizing monoclonal antibodies targeting a prominent proinflammatory cytokine in a PBMC transfer-induced humanized mouse model of systemic inflammation.MethodsInflammatory ...
Liang Zhang   +13 more
doaj   +2 more sources

Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies

open access: yesAntibodies, 2019
The development of hybridoma technology for producing monoclonal antibodies (mAbs) by Kohler and Milstein (1975) counts as one of the major medical breakthroughs, opening up endless possibilities for research, diagnosis and for treatment of a whole ...
Erik Doevendans, Huub Schellekens
doaj   +2 more sources

Role of Monoclonal Antibodies in the Treatment of Asthma [PDF]

open access: yesCanadian Respiratory Journal, 2013
BACKGROUND: Patients with severe refractory asthma represent a small subset of the asthmatic population (between 5% and 10% of all patients) but are the greatest burden to the health care system.
Paul M O’Byrne
doaj   +2 more sources

Correction: Novel humanized monoclonal antibodies against ROR1 for cancer therapy [PDF]

open access: yesMolecular Cancer
Rong Wei   +5 more
doaj   +2 more sources

Targeting cancer expressed EGFR with a humanized monoclonal antibody [PDF]

open access: yesScientific Reports
The humanization of mouse monoclonal antibodies targeting tumor antigens allows for the safe and repeated administration of therapeutic antibodies to humans.
Tamara G. Fernandes Costa   +7 more
doaj   +2 more sources

The study of pharmacodynamics of a medicine based on humanized monoclonal antibodies against IL-17 in rabbit model of antigen-induced arthritis

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
The present article contains scientific data on the assessment of specific activity of therapeutic humanized monoclonal antibodies against IL-17 in rabbit model of antigen-induced arthritis.
A. A. Nedorubov   +3 more
doaj   +1 more source

Development and evaluation of neutralizing antibodies for cross-protection against West Nile virus and Japanese encephalitis virus

open access: yesInfectious Medicine, 2023
Background: West Nile virus is a severe zoonotic pathogen that can cause severe central nervous system symptoms in humans and horses, and is fatal for birds, chickens and other poultry. With no specific drugs or vaccines available, antibody-based therapy
Meng-Jie Yang   +8 more
doaj   +1 more source

Human monoclonal antibodies and monoclonal antibody multispecificity [PDF]

open access: yesBritish Journal of Cancer, 1987
The majority of human anti-tumour monoclonal antibodies (Mabs) isolated to date have been disappointing. Firstly, they react or cross react with intracellular cytoskeletal proteins or nuclear antigens and therefore are of limited value as blood borne agents.
A M, Campbell, P, Whitford, R E, Leake
openaire   +2 more sources

Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model. [PDF]

open access: yesPLoS ONE, 2016
Clostridium difficile (C. difficile) infection (CDI) is the main cause of nosocomial antibiotic-associated colitis and increased incidence of community-associated diarrhea in industrialized countries.
Hongyu Qiu   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy